For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| CD1579 2.5% | Benzoyl Peroxide 2.5% CD1579 2.5% | None | None | 0 | 79 | 34 | 79 | View |
| CD1579 5% | Benzoyl Peroxide 5% CD1579 5% | None | None | 0 | 78 | 31 | 78 | View |
| Vehicle | Vehicle Vehicle | None | None | 1 | 79 | 26 | 79 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Compression fracture | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Ear pruritus | None | Ear and labyrinth disorders | MedDRA 15.0 | View |
| Erythema of eyelid | None | Eye disorders | MedDRA 15.0 | View |
| Conjunctivitis allergic | None | Eye disorders | MedDRA 15.0 | View |
| Abdominal pain | None | Gastrointestinal disorders | MedDRA 15.0 | View |
| Abdominal pain upper | None | Gastrointestinal disorders | MedDRA 15.0 | View |
| Diarrhoea | None | Gastrointestinal disorders | MedDRA 15.0 | View |
| Toothache | None | Gastrointestinal disorders | MedDRA 15.0 | View |
| Vomiting | None | Gastrointestinal disorders | MedDRA 15.0 | View |
| Vessel puncture site haematoma | None | General disorders | MedDRA 15.0 | View |
| Hyperbilirubinaemia | None | Hepatobiliary disorders | MedDRA 15.0 | View |
| Seasonal allergy | None | Immune system disorders | MedDRA 15.0 | View |
| Allergy to arthropod sting | None | Immune system disorders | MedDRA 15.0 | View |
| Nasopharyngitis | None | Infections and infestations | MedDRA 15.0 | View |
| Oral herpes | None | Infections and infestations | MedDRA 15.0 | View |
| Otitis externa | None | Infections and infestations | MedDRA 15.0 | View |
| Tinea pedis | None | Infections and infestations | MedDRA 15.0 | View |
| Acute tonsillitis | None | Infections and infestations | MedDRA 15.0 | View |
| Herpes simplex | None | Infections and infestations | MedDRA 15.0 | View |
| Influenza | None | Infections and infestations | MedDRA 15.0 | View |
| Laryngitis | None | Infections and infestations | MedDRA 15.0 | View |
| Pharyngitis | None | Infections and infestations | MedDRA 15.0 | View |
| Tinea versicolour | None | Infections and infestations | MedDRA 15.0 | View |
| Contusion | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Excoriation | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Hand fracture | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Ligament sprain | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Post-traumatic neck syndrome | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Radius fracture | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Arthropod bite | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Thermal burn | None | Injury, poisoning and procedural complications | MedDRA 15.0 | View |
| Protein urine present | None | Investigations | MedDRA 15.0 | View |
| Back pain | None | Musculoskeletal and connective tissue disorders | MedDRA 15.0 | View |
| Synovial cyst | None | Musculoskeletal and connective tissue disorders | MedDRA 15.0 | View |
| Headache | None | Nervous system disorders | MedDRA 15.0 | View |
| Dysmenorrhoea | None | Reproductive system and breast disorders | MedDRA 15.0 | View |
| Premenstrual syndrome | None | Reproductive system and breast disorders | MedDRA 15.0 | View |
| Rhinitis allergic | None | Respiratory, thoracic and mediastinal disorders | MedDRA 15.0 | View |
| Upper respiratory tract inflammation | None | Respiratory, thoracic and mediastinal disorders | MedDRA 15.0 | View |
| Skin irritation | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |
| Drug eruption | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |
| Eczema | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |
| Urticaria | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |
| Dermatitis allergic | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |
| Dermatitis contact | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |
| Dry skin | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |
| Eczema asteatotic | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |
| Urticaria chronic | None | Skin and subcutaneous tissue disorders | MedDRA 15.0 | View |